Table 3 |
|||||||
| BAL findings according to final interdisciplinary diagnosis | |||||||
| BAL counts (%) | Normal range | UIP/IPF | NSIP | RBILD | COP | HP | LCH |
| macrophages | >84 | 64 ± 20 | 45.3 ± 31 | 77 ± 21* | 46 ± 33 | 33 ± 18** | 86 ± 17 |
| lymphocytes | <13 | 18 ± 13 | 36 ± 27 | 14 ± 9 | 40 ± 33† | 60 ± 18†† | 4.5 ± 3 |
| neutrophiles | <3 | 10 ± 6 | 13.3 ± 11 | 6.8 ± 6.2 | 8 ±11 | 5.5 ± 5 | 7.5 ± 10 |
| eosinophiles | <0.5 | 7.5 ± 4.7 | 5 ± 6.5 | 2 ± 2 | 5.7 ± 4 | 1.3 ± 0,8 | 1.5 ± 2 |
| mast cells | <0.5 | 0.5 ± 0.4 | 0. ± 0.3 | 0.2 ± 0.2 | 0.3 ± 0.3 | 0.2 ± 0.3 | 0.5 ± 0.4 |
| CD4/CD8 | 1.1-3.5 | 1.6 ± 1.5 | 2.1 ± 1.7 | 0.6 ± 0.1 | 2 ±0.9 | 3.7 ± 2.7 | n.a. |
n.a. = not available.
* p < 0.05 vs NSIP, COP and HP.
** p < 0.05 vs UIP/IPF.
† p < 0.05 vs UIP/IPF, HP und RBILD.
†† p < 0.05 vs UIP/IPF, NSIP, COP, RBILD, und LCH.
Theegarten et al. Diagnostic Pathology 2012 7:160 doi:10.1186/1746-1596-7-160
